Research: Thymosin Alpha-1

Immune modulator — enhances T-cell function and fights infection

Thymosin Alpha-1 Research Papers & Clinical Studies

Thymosin Alpha-1 is a peptide studied for its potential therapeutic effects. Immune modulator — enhances T-cell function and fights infection This page indexes all published research papers, clinical trials, and scientific studies related to Thymosin Alpha-1 that are available in the PepsReview research library. Each paper includes metadata such as journal name, publication year, citation count, study type, and a summary of key findings. Where available, we provide direct links to the original publication and DOI references.

Researchers can use this index to quickly locate evidence supporting specific Thymosin Alpha-1 applications, compare study designs, and evaluate the strength of clinical evidence. Papers are sorted by relevance and citation count. There are currently 5 research papers indexed for Thymosin Alpha-1.

For vendor pricing, user reviews, and a complete peptide profile including mechanism of action, benefits, side effects, and regulatory status, visit the main Thymosin Alpha-1 profile page.

Thymosin Alpha-1
Thymosin alpha-1
Am J Health Syst Pharm 2001 500 Review
A pharmacy-journal review of thymosin alpha-1, an immune-modulating peptide approved in some countries as an adjunct for hepatitis B and as an immune adjuvant. Covers its mechanism, dosing used in clinical settings, and the evidence base behind its off-label immune-support use.
Thymosin alpha 1 for treatment of hepatitis C virus: promise and proof
Ann N Y Acad Sci 2010 320 Research Article
A review of thymosin alpha-1 in hepatitis C treatment, including its use alongside interferon regimens. Historical interest for understanding how immune modulators were tested as antiviral adjuvants before modern direct-acting antivirals existed.
Thymosin alpha-1 treatment in chronic hepatitis B
Expert Opin Biol Ther 2015 220 Review
A review of thymosin alpha-1 in chronic hepatitis B — an indication where the peptide is registered in some countries. Summarises clinical trial data on viral response and immune markers, which is why it remains a reference point for immune-peptide research.
Thymosin alpha 1 treatment for patients with sepsis
Expert Opin Biol Ther 2018 160 Review
A clinical review on thymosin alpha-1 for sepsis, examining immune-restoring effects in critically ill patients. One of the more serious infection-related indications studied for this peptide in peer-reviewed literature.
Thymosin Alpha 1 Plus Routine Treatment for the Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis
J Coll Physicians Surg Pak 2024 40 Clinical Trial
This systematic review was conducted to assess the curative effect of Thymosin alpha 1 in the acute exacerbation of chronic obstructive pulmonary disease (AECOPD) patients.. Six electronic databases including EMBASE, PubMed, Cochrane Library, China National Knowledge Infrastructure Database, Chinese Biomedical Database, and Wanfang Database were searched for eligible papers focusing on the.